Future Oncology Study: Augmented Intelligence to Predict 30-day Mortality in Patients with Cancer

With more than 1.6 million Americans diagnosed with cancer each year, oncology providers are turning to AI-powered prescriptive insights to deliver better care.

In a recent study published by Future Oncology, Cardinal Health Speciality Solutions, Jvion and Northwest Medical Specialties report that Jvion’s clinical AI accurately predicts short-term mortality risk among patients with cancer and guides the appropriate use of interventions and palliative care services.

  • By 2023, 2.3 million people will be newly diagnosed with cancer in the U.S.1
  • By 2030, the number of cancer survivors is projected to increase by 31.4%, to 22.2 million2

1 IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press.
2 National Cancer Institute Division of Cancer Control & Population Sciences. 2020.

Get in Touch

  • 470-427-2900, 3965 Johns Creek Court, Suite 100, Suwanee, GA 30024
  • This field is for validation purposes and should be left unchanged.

Request a Demo

  • 470-427-2900, 3965 Johns Creek Court, Suite 100, Suwanee, GA 30024
  • This field is for validation purposes and should be left unchanged.